Montana Commissioner of Securities and Insurance: Bullock Vetoes SB 71, Sides With Drug Industry Over Montanans - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Newswires
Newswires RSS Get our newsletter
Order Prints
May 10, 2019 Newswires
Share
Share
Post
Email

Montana Commissioner of Securities and Insurance: Bullock Vetoes SB 71, Sides With Drug Industry Over Montanans

Targeted News Service (Press Releases)

HELENA, Montana, May 9 -- Montana Commissioner of Securities and Insurance Matt Rosendale issued the following news release:

* * *

- Governor Condemned for Killing Lower Prescription Drug Prices

* * *

Montana Governor Steve Bullock today singlehandedly destroyed bipartisan reforms that would have lowered prescription drug costs for tens of thousands of Montanans.

By vetoing Senate Bill 71, Bullock chose to side with the pharmaceutical and insurance industries, protecting their multi-billion-dollar profits at the expense of Montanans suffering from ever-increasing prescription drug prices.

SB 71 would have saved about 70,000 Montanans an estimated $8 million on medications in the first year alone.

"This bill was a Montana solution to lower prescription drug costs. It was sponsored by a Republican in the Senate and carried by a Democrat in the House, and passed with overwhelming bipartisan support," said State Auditor Matt Rosendale. "It's simply astonishing that Governor Bullock would side with the multi-billion-dollar drug companies instead of Montanans and the doctors, pharmacists, and other health care professionals who supported the bill."

"Bullock's veto is a gift to the pharmaceutical and insurance industries and it's a slap in the face to consumers. Montanans expect much, much better from their governor," Rosendale added.

Montana doctors, pharmacists, and other health care professionals testified in favor of SB 71, as well as the state's largest union--the Montana Federation of Public Employees (MFPE)--the Trial Lawyers Association, local Montana elected officials, and national experts. The only opponents to the bill were lobbyists for various pharmacy benefit managers (PBMs) and health insurance companies.

Reactions to Bullock's veto of Senate Bill 71 were harsh:

* "I am sorry to hear that you sold out the best interests of pharmacies and patients in Montana for political contributions from the wealthy Pharmacy Benefit Managers. Montana should expect even more pharmacy failures and patients will suffer ever more limited access to needed prescription medications. Shame on you." -Gary Morrison, Registered Pharmacist (RPh), Kalispell (The Clinical Pharmacy and Medical Arts Pharmacy)

* "If SB 71, a bipartisan bill, is vetoed and PBM's are allowed to continue their current unfair and untrustworthy practices, the future of local small-town pharmacies is in great danger." -Josh Morris, PharmD, Owner of Elkhorn Pharmacy (Boulder, MT), Whitehall Pharmacy (Whitehall, MT), and Silvertip Pharmacy (West Yellowstone, MT)

* "I am disappointed that SB 71 failed due to the Governor's veto. This is a sad day for Montanans." -Sen. Al Olszewski, M.D., Kalispell, sponsor of SB 71

* "Patients are helpless participants in the health insurance marketplace. SB 71 offered protections for them against price hikes caused by kickbacks and conflicts of interests." -Marc Whitacre, M.D., Havre

* "I am very saddened to hear that Governor Bullock has vetoed SB 71. This powerful legislation was a clear step for reducing healthcare costs and his veto keeps Montanans locked into healthcare that puts big insurance companies first and patients last. He should have considered the needs of our citizens more than proving a partisan point." -Sarah Mckinney, small business owner and Havre City Council member (speaking as a private individual, not on behalf of the Council)

* "We are very disappointed that Governor Bullock vetoed this bill that would lower drug prices and hold PBMs accountable. We will keep fighting to ensure that consumers are protected and that they have access to affordable prescription drugs." -David Balto, antitrust lawyer, former Policy Director of the Federal Trade Commission (FTC)

SB 71 would have reformed the way health insurance companies contract with third-party middlemen known as pharmacy benefit managers (PBMs). The bill would have prohibited kickbacks, price gouging, and ended conflicts of interest. SB 71 would have ensured that the savings from these reforms went directly to lowering the price Montanans pay for prescription drugs as part of their insurance plans.

SB 71 was written from scratch by the State Auditor's office after a two-year investigation into rising drug costs in Montana. The bill was sponsored by Senator and orthopedic surgeon Dr. Al Olszewski, R-Kalispell, and was carried by Representative Gordon Pierson, D-Deer Lodge, in the House. The bill passed the Legislature with strong bipartisan majorities: 37-13 in the Senate and 71-27 in the House.

Rosendale's office has led the way in developing a solution to lower prescription drug costs. Other states are now adopting Montana's legislation to save their own consumers millions in drug costs. Maine has already introduced legislation modeled off SB 71, and Texas, Louisiana, Rhode Island, and others are looking at doing the same. National organizations have also recognized SB 71 as groundbreaking legislation to rein in PBMs and prescription drug costs.

Older

Genesis Healthcare: 1Q Earnings Snapshot

Newer

Quorum Health Corporation Announces First Quarter 2019 Results

Advisor News

  • Wealth planning vs. estate planning: Honoring your client’s wishes
  • What to discuss during the first retirement planning meeting
  • Inflation, competing priorities and uncertainty erode retirement security
  • As health premiums rise, 1 in 8 workers cut retirement savings
  • CT governor’s candidates claims: What’s true, and what’s misleading
More Advisor News

Annuity News

  • National Life Group expands annuity portfolio
  • AM Best to Join Life/Annuity Insurance-Focused Panel Discussion at Capitol Forum Event
  • USAA Earns No. 1 Ranking in JD Power Individual Annuity Study for the Third Consecutive Year
  • How flexible annuities fit today’s retirement portfolios
  • Foresters Financial appoints Tom Ross as chief distribution officer for U.S. annuity sales
More Annuity News

Health/Employee Benefits News

  • As WA open enrollment begins, far fewer than expected have lost coverage
  • Pennsylvania Health Plans Must Cover Colon Cancer Screening at 45
  • In Miami-Dade court, health insurer fights an order to cover $48,500 cancer drug
  • Fed judge blocks Medicaid work requirement rule
  • Health insurers leave millions unpaid for mental health crisis care in California
More Health/Employee Benefits News

Life Insurance News

  • AM Best Affirms Credit Ratings of Insignia Life S.A. de C.V.
  • FINANCIAL FRAUD
  • Security Benefit Announces Planned Dividend Rate Reset for Series B Preferred Stock
  • Palmetto Heritage and Atlantic Coast Life Announce Discussions Regarding Potential Acquisition
  • Jury finds insurance company acted in bad faith, awards Nebraska woman $11.3M
More Life Insurance News

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Press Releases

  • Spectrum Weather & Specialty Insurance Celebrates 15 Years and Welcomes the Next Generation
  • Royal Neighbors of America® Increases Service Capacity
  • Benefits Studio Launches to Fill the Missing Middle of Benefits Navigation at $49/mo
  • Lauren Sinnott Named to Ragan’s Top Women in Marketing Awards, Class of 2026 
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.